• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

    6/18/25 2:04:00 PM ET
    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Other Consumer Services
    Real Estate
    Get the next $EYEN alert in real time by email

    NEW YORK, June 18, 2025 /PRNewswire/ -- Chardan, a leading global investment banking and advisory firm, today announced an expansion into the digital asset sector, advising on and structuring a series of transactions that bridge traditional capital markets with the rapidly evolving world of blockchain and cryptocurrency.

    Chardan logo (PRNewsfoto/Chardan)

    As part of its strategic push into crypto finance, Chardan has recently served as a strategic advisor and placement agent in the following notable transactions:

    Eyenovia's $50 Million PIPE to Acquire HYPE Tokens

    Chardan acted as sole placement agent in Eyenovia Inc.'s (NASDAQ:EYEN) $50 million PIPE financing. The proceeds are being used to acquire over 1 million HYPE tokens, the native asset of the Hyperliquid blockchain, making Eyenovia the first U.S.-listed company to hold HYPE in its treasury.

    This transaction positions Eyenovia as a top validator on the Hyperliquid network and includes a strategic staking initiative in partnership with Anchorage Digital. The financing involved the issuance of non-voting convertible preferred stock and warrants, potentially raising up to $150 million in total proceeds.

    Lion Group's $600 Million Facility to Launch Hyperliquid Strategy

    Chardan acted as sole placement agent in Lion Group Holding's (NASDAQ:LGHL) $600 million facility. The facility supports the strategic accumulation of HYPE as a reserve asset, alongside Solana (SOL) and Sui (SUI). This represents LGHL's relaunch of crypto operations and its pivot toward decentralized finance infrastructure.

    VivoPower's $121 Million PIPE to Launch XRP Treasury Strategy

    Chardan acted as placement agent for the $121 million private placement for VivoPower International PLC (NASDAQ:VVPR). VivoPower is believed to be the first public company to implement an XRP-focused digital asset treasury strategy. Proceeds will be used to acquire XRP, build out a decentralized finance team, and contribute to the XRPL ecosystem.

    Classover's $500 Million Convertible Notes for Solana Treasury Strategy

    Chardan served as financial advisor to Classover Holdings, Inc. (NASDAQ:KIDZ) in its $11 million initial tranche which is the first issuance under the $500 million senior secured convertible note financing.

    Under the terms of the financing agreement, approximately 80% of the net proceeds from the initial tranche will be allocated toward the purchase of Solana (SOL) tokens, subject to certain terms and limitations.

    Classover has already acquired over 6,400 SOL tokens and is exploring additional opportunities in staking and locked token acquisitions, reinforcing its commitment to blockchain-integrated financial strategy.

    Chardan's Vision for the Future of Finance

    "These transactions underscore our commitment to leading the convergence of traditional finance and digital assets," said Jonas Grossman, President and Managing Partner at Chardan. "We are proud to support visionary companies like Eyenovia, VivoPower, Classover, and Lion Group Holding as they redefine capital allocation and treasury management in the Web3 era."

    Chardan continues to expand its digital asset advisory capabilities, offering bespoke capital markets solutions, tokenomics structuring, and blockchain integration strategies for forward-thinking clients.

    About Chardan:

    Chardan is an independent global investment bank specializing in healthcare, digital assets, technology, SPACs, and emerging growth companies. Our range of services include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access, and institutional trading. Headquartered in New York City, Chardan is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: FINRA, SIPC, and NASDAQ. 

    Chardan Media Contact:

    Emily Levine

    Chief Commercial Officer

    [email protected] 

    (475) 400-6071

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/chardan-expands-into-digital-assets-by-advising-strategic-crypto-backed-financings-302485587.html

    SOURCE Chardan

    Get the next $EYEN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $EYEN
    $KIDZ
    $LGHL
    $VVPR

    CompanyDatePrice TargetRatingAnalyst
    Eyenovia Inc.
    $EYEN
    11/18/2024$12.00 → $2.00Buy → Neutral
    H.C. Wainwright
    More analyst ratings

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Eyenovia downgraded by H.C. Wainwright with a new price target

      H.C. Wainwright downgraded Eyenovia from Buy to Neutral and set a new price target of $2.00 from $12.00 previously

      11/18/24 7:44:30 AM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • HC Wainwright & Co. reiterated coverage on Eyenovia with a new price target

      HC Wainwright & Co. reiterated coverage of Eyenovia with a rating of Buy and set a new price target of $8.00 from $6.00 previously

      4/1/21 6:45:58 AM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Northland Capital initiated coverage on Eyenovia with a new price target

      Northland Capital initiated coverage of Eyenovia with a rating of Outperform and set a new price target of $10.00

      3/1/21 9:11:48 AM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • VivoPower Commences $29 Million Shareholder Loan Financing Retirement Plan

      LONDON, July 07, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR) ("VivoPower" or the "Company") announced today that its independent directors have approved the commencement of a shareholder debt principal reduction plan. The initial repayment was made to AWN Holdings Limited ("AWN") on July 3, 2025. AWN, a private investment office, is backed by a member of Dubai's Al Maktoum ruling family, signalling institutional and sovereign wealth funding support for VivoPower and its growth objectives. The unaudited balance of the principal component of the AWN shareholder loan was $28.8 million as of June 30, 2025. The Company's objective is to retire the AWN shareholder loan i

      7/7/25 3:45:00 PM ET
      $VVPR
      Power Generation
      Utilities
    • LGHL Purchases Additional HYPE, Reaches $7 Million in Aggregate Purchases for Treasury Reserve

      SINGAPORE, July 7, 2025 /PRNewswire/ --  Lion Group Holding Ltd. (NASDAQ:LGHL) ("LGHL" or the "Company") today announced that the Company has purchased additional HYPE tokens and reached approximately $7 million in combined purchases of HYPE, SOL and SUI for its next-generation layer-1s treasury reserve. Treasury holdings as of July 7, 2025: Hyperliquid (HYPE): 128,929 tokensSolana (SOL): 6,629 tokensSui (SUI): 356,129 tokens LGHL will provide periodic updates as it expands its treasury reserve. About Lion Group Holding Ltd. Lion Group Holding Ltd. (NASDAQ:LGHL) operates an all-in-one, state-of-the-art trading platform that offers a wide spectrum of products and services, including (i) tota

      7/7/25 8:30:00 AM ET
      $LGHL
      Investment Bankers/Brokers/Service
      Finance
    • Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc.

      Name change reflects company's leadership position with its cryptocurrency treasury reserve strategy focused on the HYPE token Company to commence trading on Nasdaq under the symbol "HYPD" effective July 3rd Also announces official launch of the Kinetiq x Hyperion validator LAGUNA HILLS, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN) ("Eyenovia" or the "Company"), a pioneer in ophthalmic technologies and the first publicly-listed U.S. company to build a strategic treasury of HYPE, the native token of the Hyperliquid protocol, today announced that it is rebranding and changing its corporate name to Hyperion DeFi, Inc. Concurrent with the name change, the Company's

      7/2/25 8:00:00 AM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • FDA Approval for MYDCOMBI issued to EYENOVIA INC.

      Submission status for EYENOVIA INC.'s drug MYDCOMBI (ORIG-1) with active ingredient TROPICAMIDE AND PHENYLEPHRINE HYDROCHLORIDE has changed to 'Approval' on 05/05/2023. Application Category: NDA, Application Number: 215352, Application Classification: Type 5 - New Formulation or New Manufacturer

      5/8/23 1:05:04 PM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Rowe Michael M bought $14,077 worth of shares (27,071 units at $0.52), increasing direct ownership by 33% to 109,998 units (SEC Form 4)

      4 - EYENOVIA, INC. (0001682639) (Issuer)

      8/28/24 8:01:36 PM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Executive Officer Rowe Michael M bought $28,500 worth of shares (50,000 units at $0.57), increasing direct ownership by 152% to 82,927 units (SEC Form 4)

      4 - EYENOVIA, INC. (0001682639) (Issuer)

      8/27/24 1:06:37 PM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Large owner Grant Stuart M. bought $1,000,000 worth of shares (1,515,151 units at $0.66), increasing direct ownership by 16% to 10,914,153 units (SEC Form 4)

      4 - EYENOVIA, INC. (0001682639) (Issuer)

      7/3/24 3:18:06 PM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    SEC Filings

    See more
    • Classover Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Classover Holdings, Inc. (0002022308) (Filer)

      7/14/25 8:30:40 AM ET
      $KIDZ
      Other Consumer Services
      Real Estate
    • SEC Form PRE 14A filed by Eyenovia Inc.

      PRE 14A - HYPERION DEFI, INC. (0001682639) (Filer)

      7/11/25 8:26:03 AM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Classover Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Classover Holdings, Inc. (0002022308) (Filer)

      7/9/25 8:15:16 AM ET
      $KIDZ
      Other Consumer Services
      Real Estate

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Investment Officer Jung Hyunsu was granted 500,000 shares (SEC Form 4)

      4 - HYPERION DEFI, INC. (0001682639) (Issuer)

      7/9/25 4:04:50 PM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Jacobson Rachel was granted 5,000 shares, increasing direct ownership by 384% to 6,301 units (SEC Form 4)

      4 - HYPERION DEFI, INC. (0001682639) (Issuer)

      7/9/25 4:04:18 PM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Executive Officer Rowe Michael M was granted 6,600 shares, increasing direct ownership by 480% to 7,975 units (SEC Form 4)

      4 - HYPERION DEFI, INC. (0001682639) (Issuer)

      7/9/25 4:03:45 PM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Leadership Updates

    Live Leadership Updates

    See more
    • Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

      LAGUNA HILLS, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN) ("Eyenovia" or the "Company"), a pioneer in ophthalmic technologies and the first publicly-listed U.S. company to build a strategic treasury of HYPE, the native token of the Hyperliquid protocol, today announced several key developments in support of its digital asset capital strategy. Avenue Capital Group, now the Company's largest common stockholder, has agreed to amend Eyenovia's senior secured debt to further support the Company as it builds its HYPE treasury and reserve of the HYPE token. Pursuant to the terms of the amendment, the maturity date of the debt has been extended from November 1, 2025 to

      6/18/25 8:32:42 AM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • VivoPower to host Annual General Meeting on December 30, 2024 in London

      London, Dec. 06, 2024 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR) (the "Company" or "VivoPower") is pleased to announce that it will hold its Annual General Meeting ("AGM") at its offices in London on Monday, December 30, 2024, at 1:00 p.m. London time. The resolutions to be passed include: Laying of annual accounts and reportsDirectors' remuneration reportRe-appointment of auditorsRemuneration of auditorsExtension of the term of William Langdon appointment as director of the CompanyApproval for Mergers or Divestments The formal notice of the AGM with accompanying proxy forms and dial in details will be mailed to shareholders in accordance with the statutory period pri

      12/6/24 3:42:00 PM ET
      $VVPR
      Power Generation
      Utilities
    • Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

      NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a commercial-stage ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, today announced the appointment of experienced finance and accounting executive Andrew Jones as Chief Financial Officer. Mr. Jones brings to the Eyenovia team more than 30 years of diverse finance and accounting leadership experience spanning therapeutics and medical technology/devices, most recently serving as Chief Financial Officer of NovaBay Pharmaceuticals, Inc., a publicly traded, commercial stage ophthalmic company. Eyenovia's current CFO, John Gandolfo, is retiring and will remain with

      9/3/24 7:00:00 AM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Financials

    Live finance-specific insights

    See more
    • VivoPower Confirms Record Date for Special Dividend Eligibility for Caret Digital Spin Off

      Shareholders on record as of July 9, 2025, to receive five Caret Digital shares per VVPR share held Caret Digital subsidiary is to be spun off via a direct NASDAQ IPO at a target market capitalisation of US$308 million Negotiations are progressing with strategic pre-IPO investors in the Middle East and Asia for investment of up to US$50 million LONDON, June 24, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR, "VivoPower" or the "Company")) today announced that it has set the record date as July 9, 2025, for the purpose of determining eligibility to receive a special dividend relating to the spin-off of Caret Digital Limited ("Caret"). The implied market capitalisation

      6/24/25 3:30:00 PM ET
      $VVPR
      Power Generation
      Utilities
    • VivoPower Sets Record Date for Special Dividend Distributions Relating to Tembo Transactions

      Shareholders as at the ex-dividend date of 12 June 2025 will be eligible to receive any potential special dividend distributions relating to Tembo transactions  Corresponding record date will be 13 June 2025 LONDON, June 09, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR, "VivoPower" or the "Company")) today announced that it has set an ex-dividend date of 12 June 2025 pertaining to any potential future dividend distributions regarding transactions involving Tembo e LV B.V. ("Tembo"). Shareholders who hold VivoPower shares as of the close of business on 12 June 2025 will be entitled to receive any potential future special dividend distributions relating to Tembo. Shar

      6/9/25 10:03:00 AM ET
      $VVPR
      Power Generation
      Utilities
    • VivoPower Advances US$200 Million Tembo Transaction Following Completion of Second Phase of Due Diligence by Energi Holdings

      Energi Holdings proposes to acquire 51% of Tembo based on a total enterprise value of US$200 million Parties now agree to work towards negotiating binding transaction documents with a view to early closing Board concurrently evaluating special dividends and/or capital return to shareholders LONDON, June 03, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR, "VivoPower" or the "Company")) today announced that Energi Holdings Limited ("Energi") has advised the Company of the completion of the second phase of due diligence in connection with the previously disclosed Tembo proportional acquisition at a total enterprise value of US$200 million. Energi, headquartered in Abu D

      6/3/25 8:45:00 AM ET
      $VVPR
      Power Generation
      Utilities

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Eyenovia Inc.

      SC 13D/A - EYENOVIA, INC. (0001682639) (Subject)

      12/4/24 4:12:20 PM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Eyenovia Inc.

      SC 13G/A - EYENOVIA, INC. (0001682639) (Subject)

      11/14/24 5:08:44 PM ET
      $EYEN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by VivoPower International PLC

      SC 13G/A - VivoPower International PLC (0001681348) (Subject)

      10/4/24 4:01:08 PM ET
      $VVPR
      Power Generation
      Utilities